Understanding What Class of Drug Is Trikafta: The CFTR Modulator
•
2 min read
More than 90% of cystic fibrosis (CF) patients in the United States are eligible for treatment with Trikafta. So, what class of drug is Trikafta? It belongs to a revolutionary class of medications known as cystic fibrosis transmembrane conductance regulator (CFTR) modulators, specifically a triple-combination therapy, that directly targets the underlying genetic cause of the disease.
